Agile Capital Markets

Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)

Digital Health Innovation: Affidea Signs Partnership With Incepto To Integrate Multi-AI Solutions

Affidea, the largest European provider of advanced diagnostics, outpatient and cancer care services announces a strategic partnership with Incepto, supplier and creator of artificial intelligence solutions in the medical, sector. Through this partnership, Affidea will use Incepto platform to integrate and use 4 AI solutions in the field of oncology, neurology and breast in 14 centres in Portugal.

The Incepto platform offers Affidea’s doctors the access to a portfolio of AI solutions that Affidea is piloting under one single secured platform, directly integrated with its PACS/RIS infrastructure. Through this single platform, Affidea’s radiologists will be able to access and use in their daily clinical activity 4 different AI solutions focused on oncology, neurology and breast specialties, without changing any equipment or without having to integrate each AI software separately.

This solution comes with great benefits for patients and doctors:

  • improved patient care through AI-aided detection, measurement & diagnostics confidence;
  • operational optimization through shorter acquisition times, triage and prioritization;
  • reassurance for the medical staff.

A common vision and ambition

Over the past few years, Affidea has heavily invested in digital infrastructure and IT capabilities. With centers operating under the highest standard of quality to ensure patient safety and clinical excellence, Affidea is today the best positioned to seamlessly integrate AI in its network and embrace all the benefits expected from clinical routine usage of AI. The company has an ideal environment in terms of geographical presence, multinational clinical expertise, best technology with over 1450 pieces of equipment across 15 different healthcare markets and a team of subspecialty experts to effectively test different AI solutions. At this moment, Affidea is piloting 10 AI solutions in 10 countries within its network, allowing for further opportunitis of extending the use of Incepto platform to integrate multiple AI applications.

On its side, and with already more than 100 clinical sites using its platform , Incepto will bring to Affidea its unique expertise in integrating AI in clinical routine, both from a technical and clinical standpoint.

Related posts

DigitalHealth
admin

Incepto, the French Digital Health Specialist, is Raising €27 million to Support Its European Development

Founded in 2018, Incepto is a unique platform on the market that offers doctors and hospitals access to a portfolio of solutions based on artificial intelligence, designed to improve the quality of diagnoses, and save time for medical teams, without having to change equipment. In order to support its growth at a European scale, Incepto is raising €27 million today.

Read More »
Incepto
admin

Subtle Medical Announces Partnership Expansion With Incepto

Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced they are expanding their partnership with Incepto, a leading platform of artificial intelligence solutions for radiology professionals in Europe, by offering their AI applications, SubtleMR and SubtlePET on Incepto’s platform.

Read More »